Nano Biosols links up with Shimyatech in nano based anti viral project         September 2020

Shimyatech Ltd, a Liverpool based nanotech  R and D company has won funding from the Liverpool City Regions Future Investment Fund to develop antiviral applications targeting COVID-19.  They are developing unique nanocomposite materials to prevent surface contamination and therefore minimise virus transfer between people. Nano Biosols have entered into an agreement to collaborate on this project.

Nano Biosols has worked closely with Shimyatech in the past  in  our joint effort to create a nano-hub of commercial nanotech activity on Merseyside. Our aim is to find solutions to real world problems, particularly in the application of nanotech to the life sciences  and healthcare.

Read all about it here